GDRX vs LFMD
GDRX: GoodRx is a leading digital healthcare platform that provides price transparency and discount tools to help Americans save money on prescription medications and access healthcare services. LFMD: LifeMD is a telehealth platform connecting patients with licensed providers for remote consultations and prescription medications delivered nationwide.
Side-by-side fundamentals
| Metric | GDRX | LFMD | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $2.93 | $3.88 | |
| Market cap as of 2026-07-23 | $992M | $188M | |
| P/E as of 2026-07-23 | 48.27 | 36.02 | LFMD lower |
| PEG as of 2026-07-23 | -39.73 | -0.40 | GDRX lower |
| Net margin as of 2026-07-23 | +2.6% | +2.4% | GDRX higher |
| Gross margin as of 2026-07-23 | +91.8% | +70.5% | GDRX higher |
| Operating margin as of 2026-07-23 | +9.9% | -8.7% | GDRX higher |
| ROE as of 2026-07-23 | +3.3% | +55.3% | LFMD higher |
| ROA as of 2026-07-23 | +1.4% | +7.4% | LFMD higher |
| Debt / equity as of 2026-07-23 | 0.78 | 0.00 | LFMD lower |
| Revenue growth (YoY) as of 2026-07-23 | -1.2% | -6.2% | GDRX higher |
| Revenue CAGR (3y) SEC XBRL | +1.3% | +17.7% | LFMD higher |
| Dividend yield as of 2026-07-23 | n/a | +1.7% | |
| Beta as of 2026-07-23 | 1.59 | 2.02 | |
| 1-year return as of 2026-07-22 close | -40.4% | -62.5% | GDRX higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.